NRC Health Finance Lease, Liability, Undiscounted Excess Amount
NRC Health (NRC) had Finance Lease, Liability, Undiscounted Excess Amount of $0 as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-05
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $0.00.
- 2024-12-31: Finance Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2023-12-31: Finance Lease, Liability, Undiscounted Excess Amount $3.00K.
- 2022-12-31: Finance Lease, Liability, Undiscounted Excess Amount $9.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 |
| 2024-12-31 | $1.00K 10-K · filed 2025-03-17 |
| 2023-12-31 | $3.00K 10-K · filed 2024-02-27 |
| 2022-12-31 | $9.00K 10-K · filed 2023-03-03 |
| 2021-12-31 | $28.00K 10-K · filed 2022-03-04 |
| 2020-12-31 | $55.00K 10-K · filed 2021-03-05 |
| 2020-03-31 | $53.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $62.00K 10-Q · filed 2020-05-08 |
| 2019-09-30 | $72.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $79.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $76.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |